Envestnet Asset Management
MIST icon

Envestnet Asset Management’s Milestone Pharmaceuticals MIST Stock Holding History

Envestnet Asset Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-63,742
Closed -$150K – 4427
2024
Q4 		$150K Sell
63,742
-6,848
-10% -$11.8K ﹤0.01% 4150
2024
Q3 		$107K Buy
70,590
+11,067
+19% +$16.1K ﹤0.01% 4131
2024
Q2 		$78.6K Buy
59,523
+7,690
+15% +$12.4K ﹤0.01% 4079
2024
Q1 		$92.8K Buy
51,833
+31,163
+151% +$50.6K ﹤0.01% 4066
2023
Q4 		$34.5K Buy
20,670
+1,696
+9% +$4.6K ﹤0.01% 4003
2023
Q3 		$58.8K Buy
18,974
+918
+5% +$2.85K ﹤0.01% 3927
2023
Q2 		$51.5K Buy
18,056
+1,626
+10% +$6.13K ﹤0.01% 3868
2023
Q1 		$64.7K Buy
16,430
+2,311
+16% +$8.45K ﹤0.01% 3832
2022
Q4 		$55.9K Buy
+14,119
New +$74.3K ﹤0.01% 3859

Other funds holding MIST

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Envestnet Asset Management's MIST Position: Q1 2025 in Review

Envestnet Asset Management sold out of Milestone Pharmaceuticals (MIST) in Q1 2025, closing a stake of 63,742 shares — an estimated $150K sold.

Envestnet Asset Management first reported a position in MIST in Q4 2022 and held it in 9 quarters. The position peaked at $150K in Q4 2024. 43 funds tracked by Wall St. Rank hold MIST as of Q1 2025.

  • Envestnet Asset Management reported no remaining Milestone Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 63,742 Milestone Pharmaceuticals shares in Q1 2025, an estimated $150K.
  • Envestnet Asset Management first reported a position in Milestone Pharmaceuticals in Q4 2022 and held it in 9 quarters.
  • Envestnet Asset Management's Milestone Pharmaceuticals position peaked at $150K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2025.

Based on Envestnet Asset Management's 13F filing for Q1 2025, filed 29 Apr 2025.